Statistics for Seres Therapeutics (id:7862 MCRB)

Valuation metrics

Market cap

98.84M

Enterprise value

101.02M

Trailing P/E (ttm)

-0.86

Forward P/E

-1.05

PEG ratio

-1.05

Price/Sales (ttm)

0.78

Price/Book (mrq)

3.27

Enterprise Value/Revenue

0.80

Enterprise Value/EBITDA

-2.77

Overview

Shares outstanding

170.20M

Float

98.64M

Shares short

17.85M

% Held by insiders

0.13%

% Held by institutions

0.38%

Average volume (10 days)

2.72M

Average volume (90 days)

Price summary

52-Week low

0.54

52-Week high

2.05

52-Week change

-50.84%

Beta

2.05

50-Day moving average

0.85

200-Day moving average

0.91

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-20.17%

Operating margin

-33.56%

Operational effectiveness

Return on assets

-9.70%

Return on equity

-1,556.28%

Income statement

Revenue (ttm)

0.87

Revenue per share (ttm)

0.87

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-36,498,000.00

Net income to common (ttm)

-68,445,000.00

Diluted EPS (ttm)

-1.19

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

66.82M

Total cash per share (mrq)

0.50

Total debt (mrq)

93.61M

Total Debt/Equity (mrq)

391.37

Current ratio (mrq)

112.50%

Book value per share (mrq)

0.18

Cash flow

Cash flow statement

-103,903,000.00

Levered free cash flow (LFCF)

-113,724,000.00